Canada markets close in 51 minutes

Oryzon Genomics S.A. (ORN.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.9380-0.0040 (-0.21%)
As of 08:20AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Cost of Revenue
-13,948
-13,948
-15,234
-9,870
-8,995
Gross Profit
13,948
13,948
15,234
9,870
8,995
Operating Expenses
Selling General and Administrative
-
-
17,616
13,069
9,677
Total Operating Expenses
18,497
18,497
20,724
16,876
13,284
Operating Income or Loss
-4,549
-4,549
-5,490
-7,007
-4,290
Interest Expense
1,894
1,894
1,119
455.572
469.088
Income Before Tax
-6,104
-6,104
-6,557
-7,180
-4,779
Income Tax Expense
-2,751
-2,751
-2,325
-2,493
-1,379
Income from Continuing Operations
-3,353
-3,353
-4,231
-4,687
-3,400
Net Income
-3,353
-3,353
-4,231
-4,687
-3,400
Net Income available to common shareholders
-3,353
-3,353
-4,231
-4,687
-3,400
Basic EPS
-0.07
-
-0.08
-0.09
-0.06
Diluted EPS
-0.07
-
-0.08
-0.09
-0.06
Basic Average Shares
58,742
-
56,042
52,762
52,762
Diluted Average Shares
58,742
-
56,042
52,762
52,762